Wang, Bin
Hao, Wen
Fan, Jingyao
Yan, Yan
Gong, Wei
Zheng, Wen
Que, Bin
Ai, Hui
Wang, Xiao
Nie, Shaoping
Funding for this research was provided by:
National Natural Science Foundation of China (81870322)
Natural Science Foundation of Beijing, China (7222046, 7191002)
Beijing Nova Program (Z201100006820087)
National Key R&D Program of China (2020YFC2004800)
Article History
Received: 3 August 2022
Accepted: 16 February 2023
First Online: 1 March 2023
Declarations
:
: The study was approved by the Institutional Review Board of Beijing Anzhen Hospital, Capital Medical University (2013025) and all patients provided written informed consent.
: All the authors consent to the publication of the manuscript.
: Dr. Shaoping Nie: research grants to the institution from Boston Scientific, Abbott, Jiangsu Hengrui Pharmaceuticals, China Resources Sanjiu Medical & Pharmaceuticals, East China Pharmaceuticals. The other authors disclose no conflicts of interests.